Medical Oncologist
Medicines
How long will you be on ribociclib?
The length of ribociclib treatment depends on why it is being given. In early breast cancer it is a fixed course studied over three years, with hormone tablets continuing afterwards. In advanced breast cancer it usually continues while it works and side effects are manageable. This page explains, in general terms, what shapes the timeline and what happens when it ends.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
On this page
- How long will you take ribociclib?
- Four things that shape how long treatment lasts
- Early and advanced breast cancer compared
- The vocabulary, in plain language
- What nobody can predict at the start
- Making months or years of tablets manageable
- What happens next
- Myths about how long ribociclib is taken
- Common questions about the length of ribociclib treatment
The short answer
How long will you take ribociclib?
How long you take ribociclib, sold as Kisqali, depends mainly on whether it is being used for early breast cancer or for advanced breast cancer. In early hormone receptor positive, HER2-negative breast cancer with a higher chance of coming back, ribociclib is added after surgery and other treatment for a fixed period. In the main trial for this use, it was taken for three years, alongside an aromatase inhibitor such as letrozole or anastrozole. The hormone tablet usually continues for longer, often at least five years in total, and sometimes more. In advanced breast cancer, meaning cancer that has spread or come back and cannot be removed, there is no fixed end date. Ribociclib is usually continued for as long as it keeps the cancer under control and side effects remain manageable. For some people that is a matter of months, and for others it is several years. In both settings ribociclib is taken in cycles, usually once a day for three weeks followed by one week off, with the hormone treatment continuing through the week off. Pauses and dose reductions for side effects are common and do not necessarily shorten the planned course. Premenopausal women also receive treatment to switch off the ovaries, and men usually receive a similar hormone-lowering medicine. Your oncologist will explain which plan applies to you and review it at regular appointments.
Early breast cancer
A fixed course, studied over three years, with hormone tablets continuing afterwards.
Advanced breast cancer
No set end date; treatment continues while it works and is tolerated.
Always in cycles
Three weeks on and one week off, repeated, unless your team changes the pattern.
This page gives general information only. Your own oncologist will explain the plan that fits your situation.What decides the length
Four things that shape how long treatment lasts
The plan is set at the start, but it is reviewed as treatment goes on.
The stage of the cancer
Early breast cancer has a planned finish. Advanced breast cancer is treated for as long as the medicine keeps working.
How the cancer responds
In advanced disease, scans and symptoms show whether the cancer is controlled. Growth on scans usually leads to a change of treatment.
Side effects
Low counts, liver changes or heart rhythm changes may need a pause or a lower dose. Rarely, they mean ribociclib is stopped for good.
A lower dose usually lets treatment continue.Your own wishes
You can talk about stopping at any point. Your team will explain what that might mean.
Worth raising at reviews
- How treatment is fitting into daily life
- Side effects that are wearing you down
- Plans such as travel, work or family events
At a glance
Early and advanced breast cancer compared
Question
What generally applies
How long in early breast cancer?
A fixed course studied over three years
How long in advanced breast cancer?
As long as it controls the cancer and side effects are manageable
Which hormone treatment goes with it?
Usually an aromatase inhibitor, or fulvestrant in some advanced settings
Is the dose the same in both?
No, early breast cancer generally uses a lower starting dose
What happens after ribociclib ends?
Hormone treatment usually continues, with regular follow-up
Words you will hear
The vocabulary, in plain language
- Adjuvant treatment
- Treatment given after surgery to lower the chance of the cancer coming back.
- Advanced breast cancer
- Cancer that has spread to other parts of the body or come back and cannot be removed.
- Progression
- When scans or symptoms show the cancer is growing despite treatment.
- Cycle
- A four-week block of three weeks on ribociclib and one week off.
- Ovarian suppression
- Medicine that switches off the ovaries, used for women who have not been through menopause.
- Endocrine therapy
- Another name for hormone therapy, such as letrozole, anastrozole or fulvestrant.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Being straight with you
What nobody can predict at the start
It is natural to want a firm end date. Sometimes that is possible, and sometimes it is not.
Advanced disease has no fixed timetable
Nobody can say in advance how long ribociclib will keep advanced cancer under control. It varies widely from one person to the next.
Early disease plans can change
Side effects sometimes mean the full course is not completed. Your team will talk through what that means for you.
Longer is not always better
In early breast cancer, the course was tested over a set time. Taking it longer than planned has not been shown to add benefit.
What this page cannot tell you
It cannot tell you how long your own treatment will last. Your oncologist knows your stage, results and response.
Living with long treatment
Making months or years of tablets manageable
Whether your course is fixed or open-ended, ribociclib becomes part of daily life. Small adjustments make a real difference.
Build a routine
Take the tablets at the same time each day and mark the week off on a calendar.
Plan appointments ahead
Blood tests and ECGs are frequent early on and less frequent later. Ask for the schedule so you can plan work and travel.
Raise tiredness early
Tiredness, low mood or joint aches from hormone tablets can build up over time. There are often ways to help, so mention them.
When ribociclib stops
What happens next
The end of ribociclib is not the end of care. What follows depends on why it stopped.
Finishing a planned course
In early breast cancer, you usually carry on with hormone tablets and regular follow-up visits. Many people feel anxious when a treatment ends, and that is normal.
Stopping because the cancer has grown
In advanced breast cancer, your team will discuss other options, which may include a different hormone treatment, another targeted medicine or chemotherapy.
Stopping because of side effects
Your team will weigh whether another medicine of a similar kind, or a different approach, would suit you better.
Commonly believed
Myths about how long ribociclib is taken
If I feel well, I can stop early.
Feeling well does not show whether cancer cells remain. Talk to your team before stopping.
Everyone takes it for the same length of time.
The plan differs between early and advanced breast cancer, and between people.
A pause means I have to start the course again.
A short pause usually does not reset the course. Your team will tell you how to continue.
When ribociclib stops, all treatment stops.
Hormone therapy usually continues, and follow-up carries on for years.
Questions we are asked
Common questions about the length of ribociclib treatment
Why is the course in early breast cancer three years?
The main trial for early breast cancer tested ribociclib for three years alongside hormone tablets, so that is the period with evidence behind it. Shorter or longer courses have not been studied in the same way. Your team follows the tested plan unless side effects or other reasons make a change sensible.
Does the week off count towards the three years?
Yes. The course is measured in calendar time, and the week off is part of every cycle. Short pauses for side effects are also usually counted within the overall period. If you had a longer break, ask your team how they plan to handle the remaining time.
How will I know if ribociclib stops working in advanced disease?
Your team uses regular scans, symptoms and sometimes blood markers to check how the cancer is responding. If scans show growth, they will discuss changing treatment. New or worsening symptoms, such as bone pain or breathlessness, should be reported rather than waiting for the next scan.
Can I take a break for a family event or travel?
Sometimes a short, planned break can be arranged, but it should be agreed with your oncologist first. They can consider your stage, blood results and how long you have been on treatment. Stopping without telling anyone can make results harder to interpret.
Will the dose change during treatment?
Many people have at least one dose change, usually a reduction because of low white cell counts or other side effects. Analyses of trial data suggest people who needed a lower dose still seemed to benefit. Dose changes are always decided by your team, never on your own.
How long do I continue hormone tablets after ribociclib?
In early breast cancer, aromatase inhibitors are usually taken for at least five years in total, and some people are advised to continue for longer. The exact length depends on your risk, side effects and bone health. Your oncologist will review this with you.
Do side effects get easier the longer I take it?
Low counts and liver changes are most common in the first few months, and many people find treatment settles into a steady pattern after that. Tiredness may continue. Blood tests and ECGs also usually become less frequent once things are stable.
What if I want to stop because I am exhausted by treatment?
Your feelings matter and are worth raising openly. Your team may suggest a lower dose, support for side effects, emotional support or counselling. If you still wish to stop, they will explain the likely effect and what other protection or treatment remains.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- Cancer Research UK — Ribociclib (Kisqali)
- National Cancer Institute — Ribociclib
- Macmillan Cancer Support — Ribociclib
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.